The IUGR fetus has impaired insulin secretion responsiveness due to two primary deficits: less β-cell mass as a consequence of slower rates of β-cell proliferation and less insulin content per β-cell (Limesand et al., 2005, 2006). Here, INS is linked to fetal growth restriction.